Products
Platform
Research
Market
Learn
Compare Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 2.0 | 4.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.05 | 1.88 |
NAV | ₹19.79 | ₹40.35 |
Fund Started | 06 Oct 2020 | 25 Jun 2018 |
Fund Size | ₹165.54 Cr | ₹6103.96 Cr |
Exit Load | - | Exit load of 1% if redeemed within 15 days. |
Risk
Very High
Very High
Rating
2.0
4.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.05
1.88
NAV
₹19.79
₹40.35
Fund Started
06 Oct 2020
25 Jun 2018
Fund Size
₹165.54 Cr
₹6103.96 Cr
Exit Load
-
Exit load of 1% if redeemed within 15 days.
Returns
1 Year | 1.91% | 10.01% |
3 Year | 18.06% | 28.44% |
5 Year | - | 21.41% |
1 Year
1.91%
10.01%
3 Year
18.06%
28.44%
5 Year
-
21.41%
Holding Analysis
Equity | 99.76% | 95.89% |
Cash | -0.01% | 4.11% |
Equity
99.76%
95.89%
Cash
-0.01%
4.11%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.45% |
Max Healthcare Institute Ltd. | 6.77% |
Cipla Ltd. | 6.14% |
Divi's Laboratories Ltd. | 5.51% |
Apollo Hospitals Enterprise Ltd. | 5.28% |
Dr. Reddy's Laboratories Ltd. | 5.19% |
Eli Lilly And Co | 4.98% |
Johnson & Johnson Ltd. | 3.31% |
Torrent Pharmaceuticals Ltd. | 3.10% |
Lupin Ltd. | 3.08% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.69% |
Dr. Reddy's Laboratories Ltd. | 8.85% |
Divi's Laboratories Ltd. | 8.13% |
Cipla Ltd. | 7.54% |
Aurobindo Pharma Ltd. | 5.71% |
Lupin Ltd. | 5.11% |
Mankind Pharma Ltd. | 3.88% |
Alkem Laboratories Ltd. | 3.83% |
Biocon Ltd. | 3.64% |
Gland Pharma Ltd. | 3.20% |
Fund Manager
Name | Bhavesh Jain | Dharmesh Kakkad |
Start Date | 01 Oct 2021 | 23 Feb 2021 |
Name
Bhavesh Jain
Dharmesh Kakkad
Start Date
01 Oct 2021
23 Feb 2021
About Fund
Description | The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors. | The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. |
Launch Date | 06 Oct 2020 | 25 Jun 2018 |
Description
The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
06 Oct 2020
25 Jun 2018
